These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 1,4-Dioxane. National Toxicology Program Rep Carcinog; 2011; 12():176-8. PubMed ID: 21852832 [No Abstract] [Full Text] [Related]
5. An updated evaluation of the carcinogenic potential of 1,4-dioxane. Stickney JA; Sager SL; Clarkson JR; Smith LA; Locey BJ; Bock MJ; Hartung R; Olp SF Regul Toxicol Pharmacol; 2003 Oct; 38(2):183-95. PubMed ID: 14550759 [TBL] [Abstract][Full Text] [Related]
6. A 90-day drinking water study in mice to characterize early events in the cancer mode of action of 1,4-dioxane. Lafranconi M; Budinsky R; Corey L; Klapacz J; Crissman J; LeBaron M; Golden R; Pleus R Regul Toxicol Pharmacol; 2021 Feb; 119():104819. PubMed ID: 33189748 [TBL] [Abstract][Full Text] [Related]
7. The genotoxicity of 1,4-dioxane. Ashby J Mutat Res; 1994 Aug; 322(2):141-2. PubMed ID: 7519321 [No Abstract] [Full Text] [Related]
8. Physiologically based pharmacokinetic modeling of 1,4-Dioxane in rats, mice, and humans. Sweeney LM; Thrall KD; Poet TS; Corley RA; Weber TJ; Locey BJ; Clarkson J; Sager S; Gargas ML Toxicol Sci; 2008 Jan; 101(1):32-50. PubMed ID: 17897969 [TBL] [Abstract][Full Text] [Related]
9. 1,4-Dioxane. National Toxicology Program Rep Carcinog; 2002; 10():110-1. PubMed ID: 15323053 [No Abstract] [Full Text] [Related]
13. Two-year inhalation study of carcinogenicity and chronic toxicity of 1,4-dioxane in male rats. Kasai T; Kano H; Umeda Y; Sasaki T; Ikawa N; Nishizawa T; Nagano K; Arito H; Nagashima H; Fukushima S Inhal Toxicol; 2009 Sep; 21(11):889-97. PubMed ID: 19681729 [TBL] [Abstract][Full Text] [Related]
14. Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane. Reitz RH; McCroskey PS; Park CN; Andersen ME; Gargas ML Toxicol Appl Pharmacol; 1990 Aug; 105(1):37-54. PubMed ID: 2392805 [TBL] [Abstract][Full Text] [Related]
15. Cancer risk assessment for dioxane based upon a physiologically-based pharmacokinetic approach. Leung HW; Paustenbach DJ Toxicol Lett; 1990 Apr; 51(2):147-62. PubMed ID: 2158678 [TBL] [Abstract][Full Text] [Related]
16. Repeat-assessment of 1,4-dioxane in a rat-hepatocyte replicative DNA synthesis (RDS) test: evidence for stimulus of hepatocyte proliferation. Miyagawa M; Shirotori T; Tsuchitani M; Yoshikawa K Exp Toxicol Pathol; 1999 Nov; 51(6):555-8. PubMed ID: 10661815 [TBL] [Abstract][Full Text] [Related]
17. Chromosome breakage is primarily responsible for the micronuclei induced by 1,4-dioxane in the bone marrow and liver of young CD-1 mice. Roy SK; Thilagar AK; Eastmond DA Mutat Res; 2005 Sep; 586(1):28-37. PubMed ID: 16023405 [TBL] [Abstract][Full Text] [Related]
18. Estimating health risk from exposure to 1,4-dioxane in Japan. Makino R; Kawasaki H; Kishimoto A; Gamo M; Nakanishi J Environ Sci; 2006; 13(1):43-58. PubMed ID: 16685251 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of the mechanisms of oncogenicity of 1,4-dioxane and 1,3-hexachlorobutadiene in the rat. Stott WT; Quast JF; Watanabe PG Toxicol Appl Pharmacol; 1981 Sep; 60(2):287-300. PubMed ID: 7281189 [No Abstract] [Full Text] [Related]
20. Synthesis of novel dioxane nucleosides having two bases, physico-chemical properties, and their biological activities. Kajimoto N; Yamaizumi J; Aida M; Harada K; Maeda M Nucleic Acids Symp Ser; 1997; (37):5-6. PubMed ID: 9585971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]